This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Université De Nice Sophia Antipolis, Medincell. Active years: 2012-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2012-2022
Title: The Innovative Contributions of Marc Borsotto
Introduction
Marc Borsotto is a notable inventor based in Grasse, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of depression. With a total of 3 patents to his name, Borsotto's work is paving the way for new therapeutic approaches.
Latest Patents
Borsotto's latest patents include groundbreaking research on peptides derived from the propeptide NTSR3. These peptides are disclosed for their potential use in treating various diseases, especially depression. Another significant patent involves retro-inverso analogs of spadin, which display increased antidepressant effects. This patent describes compositions and methods for treating depression using these analogs, as well as methods for blocking TREK-1 channel activity.
Career Highlights
Throughout his career, Marc Borsotto has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Medincell. His experience in these institutions has allowed him to develop innovative solutions in the pharmaceutical industry.
Collaborations
Borsotto has collaborated with notable colleagues, including Catherine Louise Heurteaux and Jean Mazella. These partnerships have contributed to the advancement of his research and the development of new therapeutic methods.
Conclusion
Marc Borsotto's innovative work in the field of pharmaceuticals, particularly in the treatment of depression, showcases his dedication to improving mental health therapies. His patents and collaborations highlight the importance of research and innovation in addressing complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile